Atlas Trials

Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma

Clinical trial NCT03952832 · WITHDRAWN

Trial details

NCT number
NCT03952832
Sponsor
City of Hope Medical Center
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Smoldering Plasma Cell Myeloma
Start date
2019-12-11
Primary completion
2021-06-11
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.